Methylenedioxyhydroxyethylamphetamine

Methylenedioxyhydroxyethylamphetamine
Names
Preferred IUPAC name
2-{[(2H-1,3-Benzodioxol-5-yl)propan-2-yl]amino}ethan-1-ol
Other names
3,4-Methylenedioxy-N-hydroxyethylamphetamine
3,4-Methylenedioxy-1-(alpha-methylaminohydroxyethyl)ethane
MDOHET, MDHET, MDHEA
Identifiers
CAS Number
3D model (JSmol)
ChemSpider
PubChem CID
UNII
InChI
  • InChI=1S/C12H17NO3/c1-9(13-4-5-14)6-10-2-3-11-12(7-10)16-8-15-11/h2-3,7,9,13-14H,4-6,8H2,1H3 ☒N
    Key: SCUUYKMQDUDNBP-UHFFFAOYSA-N ☒N
SMILES
  • C1=C2C(=CC=C1CC(C)NCCO)OCO2
Properties
Chemical formula
C12H17NO3
Molar mass 223.271 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

MDHOET, or 3,4-methylenedioxy-N-hydroxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-hydroxyethyl analogue of MDA. MDHOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50 mg. MDHOET produces few to no effects. Very little data exists about the pharmacology, pharmacokinetics, effects, and toxicity of MDHOET.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also

References

  1. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.